Novavax Inc (NVAX)
8.715
+0.04
(+0.40%)
USD |
NASDAQ |
Dec 20, 16:00
8.72
0.00 (0.00%)
After-Hours: 20:00
Novavax Profit Margin (Quarterly): -143.5% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Moderna Inc | 0.70% |
| Inovio Pharmaceuticals Inc | -- |
| Baxter International Inc | 5.19% |
| Halozyme Therapeutics Inc | 47.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -17.08% |
| Gross Profit Margin (Quarterly) | 28.27% |
| Operating Margin (Quarterly) | -158.6% |
| Return on Net Operating Assets | -37.74% |